Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.